Arbutus Biopharma Corporation (FRA:I9DN)

Arbutus Biopharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 8, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	764	599	379	341	463	246
Market Cap Growth	31.39%	57.80%	11.19%	-26.27%	87.77%	60.15%
Enterprise Value	687	479	257	177	489	288
Last Close Price	3.91	3.03	2.27	2.12	3.23	2.90
PS Ratio	61.36	100.41	23.11	9.34	47.89	43.60
PB Ratio	11.58	6.36	3.95	2.66	3.11	2.96
P/TBV Ratio	11.58	6.36	3.95	2.66	3.11	-
EV/Sales Ratio	54.73	80.32	15.69	4.85	50.59	51.00
Debt / Equity Ratio	0.06	0.06	0.08	0.09	0.11	0.22
Asset Turnover	0.12	0.05	0.11	0.20	0.06	0.06
Quick Ratio	18.31	8.03	5.71	4.51	13.92	13.06
Current Ratio	18.80	8.15	5.87	4.60	14.32	13.39
Return on Equity (ROE)	-45.88%	-68.76%	-59.99%	-45.35%	-56.19%	-72.97%
Return on Assets (ROA)	-16.46%	-31.68%	-28.70%	-19.76%	-26.22%	-29.51%
Return on Capital (ROIC)	-20.03%	-40.08%	-36.93%	-23.40%	-28.63%	-32.60%
Return on Capital Employed (ROCE)	-33.90%	-60.30%	-64.00%	-38.90%	-37.10%	-44.90%
Earnings Yield	-4.72%	-11.28%	-17.38%	-19.05%	-14.49%	-21.15%
FCF Yield	-5.06%	-10.50%	-20.74%	-9.84%	-12.99%	-17.14%
Buyback Yield / Dilution	-5.88%	-11.84%	-9.95%	-42.07%	-40.10%	-32.83%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.